The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diagnostics PCR Market Research Report 2025
Synopsis
PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.
The global Diagnostics PCR market was valued at US$ 537 million in 2023 and is anticipated to reach US$ 626.5 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.
This report aims to provide a comprehensive presentation of the global market for Diagnostics PCR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics PCR.
Report Scope
The Diagnostics PCR market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostics PCR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostics PCR manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Bioer
Analytik Jena
Techne
Biosynex
Segment by Type
Real-Time PCR
Digital PCR
Other
Segment by Application
Hospital
Independent Laboratories
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostics PCR manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostics PCR in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
PCR is the Gold Standard in Diagnostic Testing. Polymerase chain reaction (PCR) is able to copy and multiply specific target DNA molecules has opened the door to diagnosing diseases across multiple areas quickly, accurately, and as time progresses at lower cost. Polymerase chain reaction (PCR) is a quick, easy way to create unlimited copies of DNA from just one original strand. These millions of copies of a section of DNA are made in just a few hours with the goal to recreate enough DNA for multiple testing uses, such as sequencing or infection identification.
The global Diagnostics PCR market was valued at US$ 537 million in 2023 and is anticipated to reach US$ 626.5 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Global Diagnostics PCR key players include Thermo Fisher Scientific, Bio-rad, Roche, Qiagen, Bioer, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 40%, followed by Europe and China, total have a share over 40 percent. In terms of product, Real-Time PCR is the largest segment, with a share about 55%. And in terms of application, the largest application is Hospital, followed by Independent Laboratories.
This report aims to provide a comprehensive presentation of the global market for Diagnostics PCR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostics PCR.
Report Scope
The Diagnostics PCR market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostics PCR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostics PCR manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Roche
Bio-rad
Qiagen
Agilent
Bioer
Analytik Jena
Techne
Biosynex
Segment by Type
Real-Time PCR
Digital PCR
Other
Segment by Application
Hospital
Independent Laboratories
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Diagnostics PCR manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Diagnostics PCR in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Diagnostics PCR Market Overview
1.1 Product Overview and Scope of Diagnostics PCR
1.2 Diagnostics PCR Segment by Type
1.2.1 Global Diagnostics PCR Market Value Comparison by Type (2024-2030)
1.2.2 Real-Time PCR
1.2.3 Digital PCR
1.2.4 Other
1.3 Diagnostics PCR Segment by Application
1.3.1 Global Diagnostics PCR Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Independent Laboratories
1.3.4 Other
1.4 Global Diagnostics PCR Market Size Estimates and Forecasts
1.4.1 Global Diagnostics PCR Revenue 2019-2030
1.4.2 Global Diagnostics PCR Sales 2019-2030
1.4.3 Global Diagnostics PCR Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostics PCR Market Competition by Manufacturers
2.1 Global Diagnostics PCR Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostics PCR Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostics PCR Average Price by Manufacturers (2019-2024)
2.4 Global Diagnostics PCR Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostics PCR, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostics PCR, Product Type & Application
2.7 Diagnostics PCR Market Competitive Situation and Trends
2.7.1 Diagnostics PCR Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostics PCR Players Market Share by Revenue
2.7.3 Global Diagnostics PCR Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostics PCR Retrospective Market Scenario by Region
3.1 Global Diagnostics PCR Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostics PCR Global Diagnostics PCR Sales by Region: 2019-2030
3.2.1 Global Diagnostics PCR Sales by Region: 2019-2024
3.2.2 Global Diagnostics PCR Sales by Region: 2025-2030
3.3 Global Diagnostics PCR Global Diagnostics PCR Revenue by Region: 2019-2030
3.3.1 Global Diagnostics PCR Revenue by Region: 2019-2024
3.3.2 Global Diagnostics PCR Revenue by Region: 2025-2030
3.4 North America Diagnostics PCR Market Facts & Figures by Country
3.4.1 North America Diagnostics PCR Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostics PCR Sales by Country (2019-2030)
3.4.3 North America Diagnostics PCR Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diagnostics PCR Market Facts & Figures by Country
3.5.1 Europe Diagnostics PCR Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostics PCR Sales by Country (2019-2030)
3.5.3 Europe Diagnostics PCR Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostics PCR Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostics PCR Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostics PCR Sales by Country (2019-2030)
3.6.3 Asia Pacific Diagnostics PCR Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Diagnostics PCR Market Facts & Figures by Country
3.7.1 Latin America Diagnostics PCR Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostics PCR Sales by Country (2019-2030)
3.7.3 Latin America Diagnostics PCR Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Diagnostics PCR Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostics PCR Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostics PCR Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostics PCR Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostics PCR Sales by Type (2019-2030)
4.1.1 Global Diagnostics PCR Sales by Type (2019-2024)
4.1.2 Global Diagnostics PCR Sales by Type (2025-2030)
4.1.3 Global Diagnostics PCR Sales Market Share by Type (2019-2030)
4.2 Global Diagnostics PCR Revenue by Type (2019-2030)
4.2.1 Global Diagnostics PCR Revenue by Type (2019-2024)
4.2.2 Global Diagnostics PCR Revenue by Type (2025-2030)
4.2.3 Global Diagnostics PCR Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostics PCR Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostics PCR Sales by Application (2019-2030)
5.1.1 Global Diagnostics PCR Sales by Application (2019-2024)
5.1.2 Global Diagnostics PCR Sales by Application (2025-2030)
5.1.3 Global Diagnostics PCR Sales Market Share by Application (2019-2030)
5.2 Global Diagnostics PCR Revenue by Application (2019-2030)
5.2.1 Global Diagnostics PCR Revenue by Application (2019-2024)
5.2.2 Global Diagnostics PCR Revenue by Application (2025-2030)
5.2.3 Global Diagnostics PCR Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostics PCR Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Diagnostics PCR Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Roche Diagnostics PCR Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Bio-rad
6.3.1 Bio-rad Corporation Information
6.3.2 Bio-rad Description and Business Overview
6.3.3 Bio-rad Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio-rad Diagnostics PCR Product Portfolio
6.3.5 Bio-rad Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Corporation Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qiagen Diagnostics PCR Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Agilent
6.5.1 Agilent Corporation Information
6.5.2 Agilent Description and Business Overview
6.5.3 Agilent Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agilent Diagnostics PCR Product Portfolio
6.5.5 Agilent Recent Developments/Updates
6.6 Bioer
6.6.1 Bioer Corporation Information
6.6.2 Bioer Description and Business Overview
6.6.3 Bioer Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bioer Diagnostics PCR Product Portfolio
6.6.5 Bioer Recent Developments/Updates
6.7 Analytik Jena
6.6.1 Analytik Jena Corporation Information
6.6.2 Analytik Jena Description and Business Overview
6.6.3 Analytik Jena Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Analytik Jena Diagnostics PCR Product Portfolio
6.7.5 Analytik Jena Recent Developments/Updates
6.8 Techne
6.8.1 Techne Corporation Information
6.8.2 Techne Description and Business Overview
6.8.3 Techne Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Techne Diagnostics PCR Product Portfolio
6.8.5 Techne Recent Developments/Updates
6.9 Biosynex
6.9.1 Biosynex Corporation Information
6.9.2 Biosynex Description and Business Overview
6.9.3 Biosynex Diagnostics PCR Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biosynex Diagnostics PCR Product Portfolio
6.9.5 Biosynex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostics PCR Industry Chain Analysis
7.2 Diagnostics PCR Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostics PCR Production Mode & Process
7.4 Diagnostics PCR Sales and Marketing
7.4.1 Diagnostics PCR Sales Channels
7.4.2 Diagnostics PCR Distributors
7.5 Diagnostics PCR Customers
8 Diagnostics PCR Market Dynamics
8.1 Diagnostics PCR Industry Trends
8.2 Diagnostics PCR Market Drivers
8.3 Diagnostics PCR Market Challenges
8.4 Diagnostics PCR Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
